替吉奥单药治疗老年晚期乳腺癌的疗效研究
2015-01-31詹志翔
詹志翔
替吉奥单药治疗老年晚期乳腺癌的疗效研究
詹志翔
【摘要】目的 替吉奥单药在老年晚期乳腺癌临床治疗中的效果以及作用进行分析研究。方法 选取于2013年3月~2015年7月经临床确诊并且在我院接受治疗的老年晚期乳腺癌患者77例,随机分为卡培他滨组(36例)和替吉奥组(41例),对以上两种药物的疗效进行对照研究。结果 替吉奥组患者的完全缓解率以及疾病总控制率分别为53.7% 和92.7%,均高于卡培他滨组的36.1%和72.2%,P<0.05,差异具有统计学意义。结论 替吉奥单药治疗老年晚期乳腺癌的疗效确切,并且具有很高的耐受性。
【关键词】替吉奥;老年患者;晚期乳腺癌
作者单位:464000河南省信阳市中心医院肿瘤内一科
Study on Curative Effect of Single Gimeracil and Oteracil Porassium Capsulesin in Treatment of Elderly Patients With Advanced Breast Cancer
ZHAN Zhixiang Xinyang Central Hospital The First Medicine Tumor Department in He’nan Province, Xinyang 464000, China
[Abstract]Objective Gimeracil and oteracil porassium capsulesin monotherapy in elderly patients with advanced breast cancer clinical treatment effect and the role of analysis and research. Methods Selected 77 cases with advanced breast cancer from March 2013 to July 2015 diagnosed by clinic and in our hospital, were randomly assigned to card capecitabine group(36 cases)and the gimeracil and oteracil porassium capsulesin group(41 cases), the effect of these two drugs to control study. Results The gimeracil and oteracil porassium capsulesin group of patients with complete remission rate and disease control rate was 53.7% and 92.7% respectively were higher than those in the card to cultivate capecitabine group was 36.1% and 72.2%, P<0.05, had difference statistically significance. Conclusion Gimeracil and oteracil porassium capsulesin in the treatment efficacy in treatment of elderly patients with advanced breast cancer exact,and has a very high tolerance.
[Key words]Gimeracil and oteracil porassium capsulesin, Elderly patients, Advanced breast cancer
乳腺癌是临床上一种较为常见的并且对女性身体健康和生命安全威胁极大的恶性肿瘤,对于晚期乳腺癌临床上主要以内分泌治疗、分子靶向治疗结合全身化疗等进行治疗,由于老年患者体质较弱,并且经常合并多种疾病,对于化疗无法耐受[1]。本院对2013年3月~2015年7月收治的老年晚期乳腺癌患者采用替吉奥单药治疗,取得了显著的效果,具体报道如下。
1 资料和方法
1.1一般资料
选取于2013年3月~2015年7月经临床确诊并且在我院接受治疗的老年晚期乳腺癌患者77例,年龄58~80岁,平均年龄(70.7±6.6)岁;18例浸润性小叶癌,40例浸润性导管癌,10例髓样癌,5例黏液性癌,4例单纯癌;骨转移15例,肝转移10例,肺转移35例,胸壁转移8例,锁骨上淋巴结转移9例。根据治疗药物的不同将患者随机分为卡培他滨组(36例)和替吉奥组(41例),对比两组患者的年龄、类型以及病情等一般基本资料,P >0.05,差异不具有统计学意义。……
